Ohcanbohtosat - Jessica Niswonger
- Čájehuvvo 1 - 2 / 2
-
1
Baricitinib-induced blockade of interferon gamma receptor and interleukin-6 receptor for the prevention and treatment of graft-versus-host disease Dahkki Jaebok Choi, Matthew Cooper, Karl Staser, Kidist Ashami, Kiran Vij, Bing Wang, Lynne Marsala, Jessica Niswonger, Julie Ritchey, Bader Alahmari, Samuel Achilefu, Ikuo Tsunoda, Mark A. Schroeder, John F. DiPersio
Almmustuhtton 2018Artigo -
2
CS1 CAR-T targeting the distal domain of CS1 (SLAMF7) shows efficacy in high tumor burden myeloma model despite fratricide of CD8+CS1 expressing CAR-T cells Dahkki Julie O’Neal, Julie Ritchey, Matthew Cooper, Jessica Niswonger, Luisalberto Gonzalez, Emily Street, Michael P. Rettig, Susan Gladney, Leah Gehrs, Ramzi Abboud, Julie L. Prior, Gabriel Haas, Reyka G. Jayasinghe, Li Ding, Armin Ghobadi, Ravi Vij, John F. DiPersio
Almmustuhtton 2022Artigo
Ohcanreaiddut:
Laktáseaddji fáttát
Biology
Immunology
Internal medicine
Medicine
Biotechnology
Blockade
CD8
Cancer research
Cytokine
Disease
Genetics
Graft-versus-host disease
Host (biology)
Immune system
Immunotherapy
In vivo
Interferon
Interferon gamma
Interleukin
Interleukin 2
Interleukin-1 receptor
Malignancy
Multiple myeloma
Receptor